Sulfisoxazole
From Wikipedia, the free encyclopedia
 |
|
|
Sulfisoxazole
|
|
| Systematic (IUPAC) name | |
| 4-amino-N-(3,4-dimethyloxazol-5-yl)- benzenesulfonamide | |
| Identifiers | |
| CAS number | 127-69-5 |
| ATC code | ? |
| PubChem | 5344 |
| DrugBank | APRD00595 |
| Chemical data | |
| Formula | C11H13N3O3S |
| Mol. weight | 267.305 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Sulfisoxazole is a sulfa drug based upon sulfonamide with a substituted oxazole. It is sometimes given in combination with erythromycin or phenazopyridine. It is used locally in a 4% solution or ointment.
[edit] External links
- MeSH Sulfisoxazole
- MedlinePlus DrugInfo medmaster-a601049
- MedlinePlus DrugInfo medmaster-a601115
- DDB 30455
 |
This antibiotic-related article is a stub. You can help Wikipedia by expanding it. |
